Literature DB >> 14671158

Selective reduction in cortical bone mineral density in turner syndrome independent of ovarian hormone deficiency.

Vladimir K Bakalov1, Lauren Axelrod, Jeffrey Baron, Lori Hanton, Lawrence M Nelson, James C Reynolds, Suvimol Hill, James Troendle, Carolyn A Bondy.   

Abstract

Women with Turner syndrome (TS) are at risk for osteoporosis from ovarian failure and possibly from haploinsufficiency for bone-related X-chromosome genes. To establish whether cortical or trabecular bone is predominantly affected, and to control for the ovarian failure, we studied forearm bone mineral density (BMD) in 41 women with TS ages 18-45 yr and in 35 age-matched women with karyotypically normal premature ovarian failure (POF). We measured BMD at the 1/3 distal radius (D-Rad(1/3); predominantly cortical bone) and at the ultradistal radius (UD-Rad; predominantly trabecular bone) by dual x-ray absorptiometry. Women with TS had lower cortical BMD compared with POF (D-Rad(1/3) Z-score = -1.5 +/- 0.8 for TS and 0.08 +/- 0.7 for POF; P < 0.0001). In contrast, the primarily trabecular UD-Rad BMD was normal in TS and not significantly different from POF (Z-score = -0.62 +/- 1.1 for TS and -0.34 +/- 1.0 for POF; P = 0.26). The difference in cortical BMD remained after adjustment for height, age of puberty, lifetime estrogen exposure, and serum 25-hydroxyvitamin D (P = 0.0013). Cortical BMD was independent of serum IGF-I and -II, PTH, and testosterone in TS. We conclude that there is a selective deficiency in forearm cortical bone in TS that appears independent of ovarian hormone exposure and is probably related to X-chromosome gene(s) haploinsufficiency.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14671158     DOI: 10.1210/jc.2003-030913

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Sex hormone replacement in Turner syndrome.

Authors:  Christian Trolle; Britta Hjerrild; Line Cleemann; Kristian H Mortensen; Claus H Gravholt
Journal:  Endocrine       Date:  2011-12-07       Impact factor: 3.633

Review 2.  Effects of hypogonadism on bone metabolism in female adolescents and young adults.

Authors:  Madhusmita Misra
Journal:  Nat Rev Endocrinol       Date:  2012-01-24       Impact factor: 43.330

Review 3.  New issues in the diagnosis and management of Turner syndrome.

Authors:  Carolyn A Bondy
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

4.  Reduced cortical bone density with normal trabecular bone density in girls with Turner syndrome.

Authors:  C R Holroyd; J H Davies; P Taylor; K Jameson; C Rivett; C Cooper; E M Dennison
Journal:  Osteoporos Int       Date:  2010-02-05       Impact factor: 4.507

5.  Bone mineral density in estrogen-deficient young women.

Authors:  Vaishali B Popat; Karim A Calis; Vien H Vanderhoof; Giovanni Cizza; James C Reynolds; Nancy Sebring; James F Troendle; Lawrence M Nelson
Journal:  J Clin Endocrinol Metab       Date:  2009-04-28       Impact factor: 5.958

Review 6.  Fracture risk and bone mineral density in Turner syndrome.

Authors:  Vladimir K Bakalov; Carolyn A Bondy
Journal:  Rev Endocr Metab Disord       Date:  2008-04-15       Impact factor: 6.514

7.  Turner syndrome with primary hyperparathyroidism.

Authors:  Jungmee Park; Yoo-Mi Kim; Jin-Ho Choi; Beom Hee Lee; Jong Ho Yoon; Woon-Young Jeong; Han-Wook Yoo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2013-06-30

Review 8.  A Track Record on SHOX: From Basic Research to Complex Models and Therapy.

Authors:  Antonio Marchini; Tsutomu Ogata; Gudrun A Rappold
Journal:  Endocr Rev       Date:  2016-06-29       Impact factor: 19.871

9.  Poor Compliance to Hormone Therapy and Decreased Bone Mineral Density in Women with Premature Ovarian Insufficiency.

Authors:  Anne Bachelot; Carole Nicolas; Solenne Gricourt; Jérôme Dulon; Monique Leban; Jean Louis Golmard; Philippe Touraine
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

10.  Turner's syndrome presenting as metabolic bone disease.

Authors:  Sadishkumar Kamalanathan; Karthik Balachandran; Ramesh Ananthakrishnan; Abdoul Hamide
Journal:  Indian J Endocrinol Metab       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.